EA200300429A1 - Способ получения порошковых композиций - Google Patents

Способ получения порошковых композиций

Info

Publication number
EA200300429A1
EA200300429A1 EA200300429A EA200300429A EA200300429A1 EA 200300429 A1 EA200300429 A1 EA 200300429A1 EA 200300429 A EA200300429 A EA 200300429A EA 200300429 A EA200300429 A EA 200300429A EA 200300429 A1 EA200300429 A1 EA 200300429A1
Authority
EA
Eurasian Patent Office
Prior art keywords
powder compositions
obtaining powder
obtaining
inhalation
published
Prior art date
Application number
EA200300429A
Other languages
English (en)
Other versions
EA004689B1 (ru
Inventor
Георг Бёк
Михаэль Вальц
Original Assignee
Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26007343&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200300429(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2001138022 external-priority patent/DE10138022A1/de
Application filed by Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг filed Critical Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Publication of EA200300429A1 publication Critical patent/EA200300429A1/ru
Publication of EA004689B1 publication Critical patent/EA004689B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Abstract

В заявке описан новый способ получения порошковых композиций для ингаляции.Отчет о международном поиске был опубликован 2002.06.27.
EA200300429A 2000-10-12 2001-10-09 Способ получения порошковых композиций EA004689B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10050635 2000-10-12
DE2001138022 DE10138022A1 (de) 2001-08-10 2001-08-10 Verfahren zur Herstellung von Pulverformulierungen
PCT/EP2001/011636 WO2002030390A2 (de) 2000-10-12 2001-10-09 Verfahren zur herstellung von pulverformulierungen

Publications (2)

Publication Number Publication Date
EA200300429A1 true EA200300429A1 (ru) 2003-10-30
EA004689B1 EA004689B1 (ru) 2004-06-24

Family

ID=26007343

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300429A EA004689B1 (ru) 2000-10-12 2001-10-09 Способ получения порошковых композиций

Country Status (40)

Country Link
US (2) US6585959B2 (ru)
EP (1) EP1326585B2 (ru)
JP (2) JP4986369B2 (ru)
KR (1) KR100849837B1 (ru)
CN (1) CN1269470C (ru)
AR (1) AR034166A1 (ru)
AT (1) ATE319422T1 (ru)
AU (2) AU1822002A (ru)
BG (1) BG66194B1 (ru)
BR (1) BR0114316A (ru)
CA (1) CA2425005C (ru)
CY (1) CY1105037T1 (ru)
CZ (1) CZ300022B6 (ru)
DE (1) DE50109178D1 (ru)
DK (1) DK1326585T4 (ru)
EA (1) EA004689B1 (ru)
EE (1) EE05146B1 (ru)
EG (1) EG24478A (ru)
ES (1) ES2259046T5 (ru)
HK (1) HK1060522A1 (ru)
HR (1) HRP20030277B1 (ru)
HU (1) HU229512B1 (ru)
IL (2) IL154919A0 (ru)
ME (1) ME02762B (ru)
MX (1) MXPA03003219A (ru)
MY (1) MY155912A (ru)
NO (1) NO333719B1 (ru)
NZ (1) NZ525781A (ru)
PE (1) PE20020424A1 (ru)
PL (1) PL204733B1 (ru)
PT (1) PT1326585E (ru)
RS (1) RS50495B (ru)
SA (1) SA01220518B1 (ru)
SI (1) SI1326585T2 (ru)
SK (1) SK285841B6 (ru)
TW (1) TWI283180B (ru)
UA (1) UA75375C2 (ru)
UY (1) UY26960A1 (ru)
WO (1) WO2002030390A2 (ru)
ZA (1) ZA200301349B (ru)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS50197B (sr) * 2000-10-12 2009-05-06 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Novi tiotropiumski preparati- koji sadrže prah za inhaliranje
US6443152B1 (en) * 2001-01-12 2002-09-03 Becton Dickinson And Company Medicament respiratory delivery device
WO2002096422A2 (en) * 2001-05-25 2002-12-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030008001A1 (en) * 2001-06-13 2003-01-09 Boehringer Ingelheim Pharma Kg Process for cleaning hard gelatine capsules
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
RU2004132222A (ru) * 2002-04-04 2005-10-10 Берингер Ингельхайм Фарма Гмбх Унд Ко.Кг (De) Порошковые композиции, пригодные для ингаляции
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
ATE520405T1 (de) * 2002-08-21 2011-09-15 Norton Healthcare Ltd Inhalationszusammensetzung
JP4744876B2 (ja) * 2002-08-21 2011-08-10 ノートン・ヘルスケアー リミテッド 乾燥粉末吸入組成物の製造方法
GB0219513D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
DE10351663A1 (de) * 2002-12-20 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverförmige Arzneimittel enthaltend ein Tiotropiumsalz und Salmeterolxinafoat
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
DE10331350A1 (de) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
DK1699434T3 (da) 2003-09-02 2011-05-30 Norton Healthcare Ltd Fremgangsmåde til fremstilling af et lægemiddel
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
CA2544357A1 (en) 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
KR20060117334A (ko) 2003-11-03 2006-11-16 베링거 인겔하임 인터내셔날 게엠베하 티오트로피움 염의 제조방법, 티오트로피움 염 및 이를함유하는 약제학적 조성물
PL1691783T3 (pl) * 2003-12-03 2010-05-31 Boehringer Ingelheim Int Inhalator suchego proszku ze wstępnym odmierzaniem do leków wrażliwych na wilgoć
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
NZ556709A (en) 2005-02-10 2009-09-25 Glaxo Group Ltd Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
GB0507835D0 (en) * 2005-04-18 2005-05-25 Solexa Ltd Method and device for nucleic acid sequencing using a planar wave guide
WO2006117299A2 (en) 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
EP2011538B1 (en) 2007-07-06 2016-02-17 Vectura Delivery Devices Limited Inhaler
ES2388494T3 (es) * 2007-07-27 2012-10-15 Cargill, Incorporated Micronización de polioles
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
CA2723806C (en) 2008-05-09 2022-05-31 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
CN102119238B (zh) * 2008-07-24 2014-05-28 乔治洛德方法研究和开发液化空气有限公司 沉积含过渡金属的膜的方法
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
KR101722290B1 (ko) 2009-10-27 2017-03-31 호라이라 인코포레이티드 냉각 가능한 에너지 에미팅 어셈블리를 갖는 전달 장치
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
CN102711645B (zh) 2009-11-11 2016-12-28 赫莱拉公司 用于处理组织和控制狭窄的系统和装置
US9259376B2 (en) 2010-06-03 2016-02-16 Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. Process for dry powder formulations
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
ES2701525T3 (es) 2014-07-09 2019-02-22 Arven Ilac Sanayi Ve Ticaret As Un procedimiento para la preparación de formulaciones para inhalación
PL3175842T3 (pl) * 2015-12-03 2020-06-29 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Sposób mieszania suchego proszku
EP3826620A4 (en) * 2018-07-12 2023-03-08 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi INHALATION COMPOSITIONS CONTAINING DOPAMINE GONISTS
WO2022146255A1 (en) * 2020-12-31 2022-07-07 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi A process for the preparation of dry powder compositions for inhalation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
US3860618A (en) 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
BE891013A (fr) † 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
JPS60150823A (ja) * 1984-01-17 1985-08-08 Satake Eng Co Ltd 穀物混合装置
JPH0439388A (ja) * 1990-06-04 1992-02-10 Teijin Ltd 土砂と繊維状物との混合方法
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
JPH06198156A (ja) * 1993-01-06 1994-07-19 Nagasaki Pref Gov 噴霧積層混合器
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
ES2192866T3 (es) * 1998-11-13 2003-10-16 Jago Res Ag Polvo seco para inhalacion.
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ME02762B (me) 2011-05-10
JP4986369B2 (ja) 2012-07-25
NZ525781A (en) 2004-11-26
DK1326585T4 (da) 2011-01-10
EP1326585B1 (de) 2006-03-08
JP2009197025A (ja) 2009-09-03
TWI283180B (en) 2007-07-01
HK1060522A1 (en) 2004-08-13
WO2002030390A2 (de) 2002-04-18
ES2259046T5 (es) 2011-02-28
KR100849837B1 (ko) 2008-08-01
HUP0301268A3 (en) 2005-05-30
KR20030051706A (ko) 2003-06-25
CA2425005C (en) 2008-08-05
AU2002218220B2 (en) 2006-06-15
US20020106332A1 (en) 2002-08-08
EG24478A (en) 2009-08-03
AU1822002A (en) 2002-04-22
DK1326585T3 (da) 2006-05-22
NO20031692D0 (no) 2003-04-11
SI1326585T1 (sl) 2006-06-30
US6585959B2 (en) 2003-07-01
EE200300170A (et) 2003-06-16
WO2002030390A3 (de) 2002-06-27
UA75375C2 (en) 2006-04-17
NO20031692L (no) 2003-06-06
CZ300022B6 (cs) 2009-01-14
JP2004510806A (ja) 2004-04-08
HUP0301268A2 (hu) 2003-10-28
SK4372003A3 (en) 2003-07-01
YU27403A (sh) 2006-03-03
CY1105037T1 (el) 2010-03-03
ATE319422T1 (de) 2006-03-15
PL362511A1 (en) 2004-11-02
MY155912A (en) 2015-12-15
CA2425005A1 (en) 2003-04-04
HRP20030277B1 (en) 2011-09-30
RS50495B (sr) 2010-03-02
MEP42708A (en) 2011-02-10
PE20020424A1 (es) 2002-07-02
ZA200301349B (en) 2004-06-30
MXPA03003219A (es) 2004-12-03
SA01220518B1 (ar) 2006-12-10
BG66194B1 (bg) 2012-01-31
EP1326585A2 (de) 2003-07-16
HU229512B1 (en) 2014-01-28
HRP20030277A2 (en) 2005-02-28
EP1326585B2 (de) 2010-09-29
BR0114316A (pt) 2003-08-26
NO333719B1 (no) 2013-09-02
UY26960A1 (es) 2002-06-20
CN1269470C (zh) 2006-08-16
PT1326585E (pt) 2006-05-31
CN1469733A (zh) 2004-01-21
SK285841B6 (sk) 2007-09-06
IL154919A0 (en) 2003-10-31
SI1326585T2 (sl) 2011-01-31
PL204733B1 (pl) 2010-02-26
EA004689B1 (ru) 2004-06-24
AR034166A1 (es) 2004-02-04
IL154919A (en) 2011-01-31
USRE38912E1 (en) 2005-12-06
DE50109178D1 (de) 2006-05-04
BG107673A (bg) 2003-11-28
EE05146B1 (et) 2009-04-15
ES2259046T3 (es) 2006-09-16

Similar Documents

Publication Publication Date Title
EA200300429A1 (ru) Способ получения порошковых композиций
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
PT1109812E (pt) Pirrolobenzodiazepinas
JO2410B1 (en) 6. Replaced pyrido-pyrimidines
EA200001102A1 (ru) Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
GB0124627D0 (en) Novel compounds
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
ITUD20030092A1 (it) Protesi per l'articolazione della spalla.
RS50071B (sr) Novi oblik soli pantoprazola
AU6233201A (en) Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
EE200300218A (et) Latentse antitrombiin III valmistamise meetod
EP1426370A4 (en) PROPANOLAMINE DERIVATIVE WITH 1,4-BENZODIOXANE CORE
WO2002053519A3 (en) Hydrophobic polyamine analogs and methods for their use
HK1045990A1 (en) Novel derivatives and analogues of galanthamin.
DE69834107D1 (de) Gaserzeugende Zusammensetzungen
MXPA04003755A (es) Endoprotesis vasculares.
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
ATE365036T1 (de) Creatinester-pronutrient-verbindungen und formulierungen
MY134966A (en) Alkaline earth metal complexes and their use
IT1320107B1 (it) Procedimento per la preparazione di derivati tassanici.
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
EA200200798A1 (ru) Кальцилитические соединения
BR0101437A (pt) Método para preparar um ciclopropeno
DE50107490D1 (de) Stoffgemisch enthaltend bisphenol a

Legal Events

Date Code Title Description
MK4A Patent expired

Designated state(s): AM AZ BY KZ KG MD TJ TM RU